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Abstract
Objective: To examine how FFS Medicare utilization of endoscopy procedures for colorectal cancer (CRC) screening
changed after implementation of the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) in
2006, which provided subsidized drug coverage and expanded the geographic availability of Medicare managed
care plans across the US.
Data Sources/Study Setting. Using secondary data from 100% FFS Medicare enrollees, we analyzed endoscopy
utilization during two intervals, 2001-2005 and 2006-2009.
Study design: We examined change in predictors of county-level endoscopy utilization rates based on a
conceptual model of market supply and demand with spillovers from managed care practices. The equations for
each period were estimated jointly in a spatial lag regression model that properly accounts for both place and time
effects, allowing robust assessment of changes over time.
Data collection/Extraction methods: All Medicare FFS enrollees with both Parts A and B coverage who were age
65+, remained alive and living in the same state over the interval were included in the analyses. The later interval
used a new cohort defined the same as the earlier interval. 100% Medicare denominator files were also used,
providing county of address to use for county-level aggregation. The outcome variable was defined as county-level
proportion of enrollees who ever used endoscopy over the interval.
Principal findings: Endoscopy utilization by FFS Medicare increased, and became more accessible across the US.
Medicare managed care plan spillovers onto FFS Medicare endoscopy utilization changed over time from a
significant negative (restraining) effect in the early period to no significant effect by the later period.
Conclusions: The MMA eased budget constraints for seniors, making endoscopic CRC screening more affordable.
The MMA policies also strengthened managed care business prospects, and enrollments in Medicare managed care
escalated. The change in managed care spillover effects reflects the gradual acceptance of endoscopic CRC
screening procedures, as they emerged as the gold standard during the period.
Background
Utilization of endoscopic procedures (colonoscopy, sig-
moidoscopy) for colorectal cancer (CRC) screening is
effective in preventing precancerous tumors from develop-
ing into cancer, however the utilization rate is lower than
recommended guidelines [1–3]. In 2001, the Centers for
Medicare and Medicaid Services (CMS) expanded Medi-
care coverage to cover colonoscopy for persons with
average risk for CRC, in the face of an emerging body of
cost-effectiveness research on endoscopy screening for
CRC and evidence recommending use of colonoscopy [4].
Over the next six years, utilization of colonoscopy diffused
rapidly across FFS Medicare markets, and came to domin-
ate the endoscopy services. At first, the expansion occurred
in those markets with more favorable business prospects,
and was slower to diffuse to minority-dominated areas [5].
Although the expansion in coverage for endoscopy helped
improve uptake of endoscopic screening procedures, it still
left the beneficiary facing substantial out-of-pocket copay-
ments and facility fees, and utilization rates were subopti-
mal according to emerging screening guidelines.
In 2006, the implementation of the Medicare Prescription
Drug, Improvement, and Modernization Act (MMA) offered
subsidized prescription drug packages to seniors, available to
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both traditional fee-for-service (FFS) enrollees and man-
aged care plan enrollees. The savings afforded by the drug
plan coverage might have loosened budget constraints for
many seniors, perhaps making the endoscopy copayments
more affordable. Thus it is reasonable to expect that there
might have been an increase in demand for endoscopic CRC
screening after implementation of the MMA in 2006.
In addition, the MMA led to considerable expansion
in the Medicare managed care program across the US.
The Act renamed the Medicare + Choice program the
Medicare Advantage (MA) program, and made it much
more attractive to seniors by adding prescription drug
coverage to all MA plans [6]. CMS also re-defined the
so-called ‘CMS Regions’ into ten new areas configured
to enhance expansion of MA plans into all areas of the
US ([7]; CMS [8]). The Medicare managed care penetra-
tion rate increased from 15% in 2000 to 24% in 2010
and continued to increase thereafter [9]. Figure 1 shows
the penetration by Medicare MA plans in 2005 (before
The Act was implemented), and in 2015 (most recent
data available) across the ten CMS regions.
Managed care plans have been reputed to disseminate
best-practice guidelines and encourage use of preventative
services with established cost-effectiveness evidence. Man-
aged care penetration may have helped encourage the dif-
fusion of colonoscopy as a CRC screening procedure. In
2008, colonoscopy was recommended as one of the
primary colorectal cancer screening tests by the
United States Preventive Services Task Force, follow-
ing a systematic review of studies demonstrating col-
onoscopy as a cost-effective CRC screening procedure
[10–12]. Since then one might expect that managed
care practices would embrace and disseminate this in-
formation, resulting in an increase of colonoscopy
utilization for CRC screening. Such a phenomenon
may also spill over to non-managed care enrollees, as
prior studies have shown managed care practices influence
and spill over onto other market constituents, including
Medicare FFS enrollees [13, 14]. For example, using data
from 1999 and 2001-2006, two studies found modest spill-
over effects from MA penetration on FFS Medicare
utilization of endoscopy for CRC screening [5, 15]. There-
fore, it is reasonable to expect that the demand for endo-
scopic CRC screening increased for FFS Medicare
enrollees through spillover effects from MA penetration
after implementation of the MMA.
Fig. 1 Medicare Managed Care Penetration Across the Ten CMS Regions, Before and After the MMA
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In this study, we exploited the natural experiment pro-
vided by the MMA implementation in 2006, to deter-
mine how the changes in market conditions during this
decade predicted utilization of endoscopic CRC screen-
ing among the aged. The focus is on the traditional FFS
Medicare enrollees for whom complete medical claims
exist for study. Relaxation of personal budget constraints
due to newly available subsidies, and market spillover
effects emanating from managed care expansion are




We adapt the conceptual model used in published studies
which included a comprehensive set of supply and de-
mand factors that would determine the feasibility of estab-
lishing endoscopic CRC screening services in a given
market [5, 16]. Acquisition of endoscopy equipment and
the necessary training to use it will depend on the ex-
pected return on investment, which is a function of mar-
ket conditions. Observed utilization rates will depend on
various market factors, summarized in Table 1, which de-
scribes the variables we use to capture these aspects.
From the perspective of determinants of market po-
tential, we use demographic factors defined for all Medi-
care eligibles (including those under age 65) from the
Medicare denominator file to characterize the age distri-
bution, race or ethnicity, and vulnerability in the Medi-
care population. Vulnerability is defined as eligibility for
additional benefits to assist the low income (who may be
dually eligible for Medicare and Medicaid benefits), the
disabled, and those with end-stage renal disease (ESRD).
This measure of vulnerability also captures some degree
of medical need or comorbidity. Areas with higher per-
centages of vulnerable beneficiaries are not expected to
be as manageable or as profitable for managed care
plans that were reluctant to expand into all markets after
experimental demonstrations by CMS offered substantial
subsidies [17]. The acculturation, educational attain-
ment, and area poverty variables capture aspects of de-
mand for the services. The first two are defined for
persons aged 65+, while area poverty is defined as aver-
age area poverty over two decades. Better educated eld-
erly with good English language skills are expected to
have a better grasp of the benefits and a greater demand
for endoscopic screening. Persistently poorer areas are
not expected to be attractive to entry by endoscopy pro-
viders. Market size, which affects the pace of return on
investment, is reflected in population density and the
percent of the population with Medicare Part A benefits.
We surmise that the higher the percentage of the popu-
lation with Medicare Part A benefits, the more import-
ant is Medicare as a demand segment in the market.
Health market conditions are reflected by the geographic
density of endoscopy providers, measured as the average
distance among FFS claimants to providers closest to their
ZIP code of residence, and a competition index among en-
doscopy providers (an inverse Herfindahl index, where
0 = no competition and 1 =maximal competition). An-
other health market condition factor is the prevalence of
Medicare managed care plans, which may have spillover
effects on FFS enrollee utilization rates.
Managed care spillovers
There has been sustained interest over the years in the
impacts of managed care plans on other market partici-
pants, the so-called ‘spillover effects’ of managed care.
Defined as changes in financial incentives, physician
practice patterns, costs, or the diffusion of new technol-
ogy relative to what might occur in markets with little
managed care influence - spillovers have been examined
empirically for over twenty years [5, 13, 14, 18–24].
Changes in practice patterns for a substantial propor-
tion of insured patients can spill over to people who are
not insured by the managed care plans (including the
FFS Medicare population) who are seen by the same
physicians influenced by the managed care practices and
protocols. Also, individuals not enrolled in managed care
plans might compare prescribed treatment options with
their peers who are enrolled in managed care plans. These
behavioral spillovers among people and physicians ensure
that managed care plans can impact the way medicine is
practiced in their markets. With particular relevance to
this study, managed care spillovers can impact adherence
to CRC screening guidelines by patients, irrespective of
whether they are enrolled in managed care plans.
To obtain robust and reliable estimates for these spill-
overs onto FFS Medicare utilization, empirical models
must deal with sources of selection bias that could influ-
ence the estimates [5, 13]. Selection effects can be re-
lated to the relative generosity of MA plan versus FFS
plan payment rates, the fact that wealthier elderly would
have to give up supplemental coverage to enroll in man-
aged care, the benefits to lower income elderly of obtain-
ing ‘free’ Part B coverage by enrolling in managed care
plans, and other socio-economic factors varying from
place to place [5, 18, 25–27]. These socio-economic fac-
tors are expected to impact the demography of enroll-
ment into MA plans, and the specifics of particular
markets that MA plans may choose to enter. Factors
among the Medicare population such as lower income
or greater morbidity, age distribution, and racial or eth-
nic concentrations that vary from place to place are all
factors that may have impacted where MA plans origin-
ally entered and attracted enrollees. After the MMA im-
plementation in 2006, MA plans spread across the US to
enter new markets not previously served, where spillover
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effects might reach fertile new ground. So there are
many reasons to expect changes over time in the eco-
logical model of county-level utilization of endoscopic
CRC screening by the FFS Medicare population.
Analysis samples, outcomes, and contextual factors
To examine how the MMA may have influenced endo-
scopic CRC screening utilization for the Medicare FFS
enrollees, we constructed the population-based study
sample in two cohorts based on the 100% FFS insured
Medicare enrollees. First, we included the entire Medi-
care FFS population aged 65+ each year during 2001-
2005, or 2006–2009. We then excluded all persons who
did not have traditional FFS Medicare coverage (defined
as both Parts A and B coverage for at least 11 months of
the year) for all years in each interval. We excluded
people who died or who moved to a different state dur-
ing the interval, and a new cohort was derived using
these criteria for the second interval. Current CRC
screening guidelines for persons of average risk from the
USPSTF recommend fecal occult blood testing (FOBT)
every year, sigmoidoscopy every 5 years, and colonoscopy
every 10 years. We focus only on the diffusion of endos-
copy services because they are costly to provide and their
availability is expected to fluctuate with market conditions.
Following the approach in a previous study, we focus on
‘any utilization’, rather than attempting to ascertain opti-
mal utilization patterns for each beneficiary, which is be-
yond the scope of this paper [5]. Focusing on ‘any
utilization’ allows us to ascertain availability and diffusion
of the services as predicted by market influences.
We first created an indicator for whether or not an in-
dividual had ever used either of the services over the
interval. Services were defined using a comprehensive
list of medical procedure codes consistent with other
studies of endoscopic technology utilization for CRC
Table 1 Market conditions fostering FFS Medicare utilization of endoscopy services, and variables used in modeling
2001-2005 2006-2009
Mean St. Dev Mean St. Dev Source
Dependent Variable: Avg. Annual % Endoscopy Utilization 7.4 1.2 7.9 1.3 100% of traditional FFS Medicare
endoscopy claims
Market Demographics of the Medicare population (%)
Age < 65 16.9 6.1 18.4 6.1 100% Medicare denominator files,
averages 2001-2005; 2006-2010
Age 65-74 44.5 3.7 43.5 3.9
Age 75-84 28.6 3.6 27.2 3.5
Age 85+ 9.9 2.4 10.9 2.8
Female 55.0 2.8 54.2 2.5
Caucasian 90.6 13.2 90.2 13.5
African American 7.3 12.7 7.5 12.9
Hispanic 1.0 3.2 1.0 2.9
Asian 0.3 0.8 0.3 1.0
American Indian and other races/ethnicities 0.8 4.3 1.0 4.9
Dual/ESRD/disabled benefits 20.9 10.7 27.9 10.6
Acculturation and educational attainment of the market population, and area poverty:
Persons Aged 65+ with little or no English language ability (2000) 14.3 14.7 14.3 14.7 US Census 2000; American
Community Survey, 2006-2010;
Census SAIPEPersons aged 65+ with graduate or professional degrees (2000; 2006-2010) 4.4 2.8 5.7 4.0
Average poverty in the area over the past 20 years (1990-2000; 1995-2005) 14.8 6.7 14.1 5.7
Market size, which affects pace of return on investment:
Population density (2000, 2005) per sq. mile 235.1 1661.8 242.8 1713.4 Area Health Resource Files
Percent of the population with Medicare Part A benefits (2001, 2006) 14.1 2.0 14.8 2.0
Health market conditions:
Prevalence of managed care plans: Medicare managed care penetration,
lagged 1 year (2000, 2005)
4.9 9.7 4.6 8.4 RTI Spatial Impact Factor Database
Prevalence of endoscopy providers: average distance from FFS claimants
to closest provider (2001, 2006)
10.4 8.8 11.7 9.2
Competition among endoscopy providers (2001, 2006) index, where
1 = perfect and 0 = no competition
0.020 0.046 0.021 0.052
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screening (G0104,G0105,G0121,44388-44397,45300, 45305,
45308, 45309, 45315, 45317, 45320, 45327,45330,45331,
45333-45335, 45338-45342, 45345, 45355, 45378-45387,
45391, 45392) [2, 5, 15]. Procedures include, among other
things, ‘screening with polyp removal and biopsy’, which in-
surers view as ‘diagnostic’. We include these because this
more complex endoscopic procedure is prescribed by the
endoscopy guidelines to meet the gold standard of screen-
ing for CRC. If the person used endoscopy more than once,
the county of residence at first use was kept as the county
of record for the analysis.
The sum of these person-level endoscopy utilization
indicators by county is the numerator used in creating
the county proportion of all traditional FFS Medicare
enrollees (defined above) who had ever used one of the
services over the interval. Because the early period is
1 year longer than the late period, and we desire a fair
comparison of changes in utilization rates over time, we
created the average annual utilization rate in each period
by dividing the multi-year construct by the number of
years it spanned. Thus the outcome variable of interest
is the average annual utilization rate in the county for
endoscopy services used during 2001-2005 or 2006-
2009, among traditional FFS Medicare enrollees. The
county-level proportion was defined separately for each
county and time interval, and converted to a percentage
for use in the analysis.
For the market contextual factors, we used 100%
Medicare population demographic information from the
Medicare denominator files to describe characteristics of
beneficiaries, including age groups, sex, race or ethnicity,
and vulnerability (Dual, disabled, ESRD) status. Averages
over the intervals were used to represent these compos-
itional factors. Other factors describing local market con-
ditions were drawn from the U.S. Census and American
Community Survey, the Area Health Resources Files, and
the RTI Spatial Impact Factor database (see Table 1).
These ecological variables together reflect aggregate mar-
ket conditions in all counties across the continental
United States, over the two time periods. Managed care
penetration was defined for a one-year lag prior to
each interval (2000 for 2001-2005; 2005 for 2006-2009) to
reduce potential endogeneity. This variable was con-
structed from the CMS Geographic Service Area files,
which provide the county number and proportion of
enrollees in various types of plans (including managed
care plans) by county.
Descriptive analyses
We calculated descriptive statistics for the variables we in-
cluded in the statistical models, for the early (2001-2005)
and late (2006-2009) periods, summarized in Table 1.
In addition, we used mapping of the average annual
utilization rates by county in each period to discern
whether there was apparent diffusion of these services
over the geography of the US (Fig. 2). Using the same
cutpoints in the two figures allows a fair comparison
over time of the average annual percent of FFS Medi-
care enrollees ever using these services each period. It
is evident from a comparison of the two periods that
average utilization increased over time and diffused or
spread out over more geographic areas over time, as
endoscopy became an accepted component of the
gold standard for CRC screening.
Statistical analysis
To estimate the associations between ecological factors
and market outcomes, and how these may have changed
over time, the challenge is to simultaneously handle two
data correlation issues: (1) adjacent county observations
on the screening utilization outcome may be spatially
correlated, and (2) the county observations themselves
may be correlated over time. Both situations may lead to
reduced efficiency and reliability of statistical inference,
and the first may result in spatial multiplier bias. We use
the spatial seemingly unrelated regression (SSUR) empir-
ical model that deals with both of these aspects.
First, we expected to see evidence of statistically sig-
nificant spatial autocorrelation. Spatial autocorrelation
across adjacent areas in outcomes related to public
goods or preventive health care services that are expen-
sive to provide is well documented in the empirical lit-
erature [28–32]. Because the decision regarding whether
to establish endoscopy services in a county may be af-
fected by prevalence of these services in adjacent coun-
ties, we expect there will be spatially correlated errors in
the ecological models. Ignoring this is equivalent to
falsely assuming that observations (county utilization
rates) are statistically independent, which is a standard
assumption under ordinary least squares (OLS) regression.
This can lead to either efficiency bias, parameter bias, or
both [33]. Recent papers have shown that ignoring spatial
spillovers can yield highly inflated estimates of the mar-
ginal impact of living in rural poverty on preventive care
service utilization by the elderly, misleading antitrust pre-
scriptions, and inflated estimates of managed care spill-
over effects [5, 31, 32]. These misspecification effects can
be corrected using a spatial regression model.
The second problem facing the ecological model is the
possibility that area rates may be correlated over time.
Ignoring this source of similarity or redundancy in the
data inflates statistical significance. To reliably ascertain
whether observed changes in parameter estimates over
time are statistically significant, it is important to use an
estimation setup that pools the two time periods and al-
lows the two cross-sectional equations to have correlated
errors over time. Thus, in estimation, we need an empir-
ical approach that can deal with both spatial and time
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correlation. We adopt the seemingly-unrelated regressions
(SUR) approach pioneered by Zellner [34], and expanded
to include spatial autocorrelation by Anselin [33]. We
used the residuals from OLS regression as diagnostics to
test for spatial correlation and determine the best spatial
model to employ. We then estimated a spatial lag model
specification to perform the spatial regressions over the
early (2001-2005) and late (2006-2009) time periods, in-
corporated within a seemingly unrelated regression (SUR)
framework, which allowed us to pool the two equations
over time [33, 35, 36]. All models were estimated using
PySAL, a Python library for spatial analysis developed by
the GeoDa Center for Geospatial Analysis and Computa-
tion [37]. The programming code for the spatial SUR
models is now publicly available for general applications
as part of PySAL, as described in a recent applied spatial
econometrics textbook [36].
The spatial SUR (SSUR) model allows for spatially cor-
related error terms within each equation and across
equations, with separate parameter estimates for each
time period. To assess diffusion effects, we performed
parameter-specific Wald tests to test for the stability of
parameters across time. The null hypothesis under the
Wald test is that parameters are stable (do not change
significantly) over time. When this hypothesis is rejected,
we can conclude that a significant change over time
occurred; these are indicated with asterisks on the vari-
ables named in Table 2. The PySAL software also pro-
vides a Lagrange Multiplier test to assess whether the
SUR simultaneous-equation estimation significantly im-
proves the efficiency of the effect estimates (relative to
an unpooled model).
Results
Characteristics of the samples
Figure 2 shows the average annual utilization rates for
the FFS Medicare cohorts defined for the two periods.
Many counties show annual utilization rates of less the
8%. However, it is apparent when comparing the figures
that utilization rates increased over time, increasing the
Fig. 2 Average Annual Utilization of Endoscopic CRC Screening in FFS Medicare, in Two Periods Pre- and Post MMA of 2006
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geographic coverage of counties with more than 8%
average annual utilization.
Table 1 summarizes the set of supply and demand
conditions used in the regression modeling. Sample sta-
tistics show means and standard deviations for the
county-level data, as well as data sources. The average
annual endoscopy utilization among the traditional
Medicare enrollees increased slightly over time, from 7.4
to 7.9 percent. The average percentage across counties
of all Medicare beneficiaries in the youngest and the old-
est age groups increased, and the percentage of vulner-
able people eligible for extra benefits (DUAL, disabled,
ESRD) increased from 20.9 to 27.9 percent. The percent-
age of over age 65 with graduate or professional degrees
increased slightly, as did population density, and the per-
cent of the Medicare Part A coverage market increased
from 14.1 to 14.8. All health market conditions, includ-
ing MA plan penetration were fairly stable.
Estimates from multivariate analyses
Table 2 presents the results from both ordinary least
squares (OLS) and SSUR regressions. The SSUR models
include a spatial lag parameter in addition to other coef-
ficient estimates. The results are very similar across the
model types, where statistically significant results for
each model are highlighted in bold font (Table 2). For
both models, the Lagrange Multiplier test (not shown)
allowed us to conclude that the SSUR model improved
efficiency significantly as compared to an unpooled
model, and parameter-specific Wald tests found many
significant changes in parameters over time, as indicated
by superscripted lowercase letter a. The significance
of changes over time were consistent across the OLS
and the spatial lag regressions. The spatial lag esti-
mate is fairly small but statistically significant; the
small lag effect is consistent with the similarity of es-
timates across the OLS and SSUR models.
First we discuss the demographic characteristics of the
Medicare population, and how these are associated with
the average annual endoscopy utilization rates in the
counties they represent. Places with higher percentages
of older Medicare populations saw lower screening rates,
and they dropped significantly over time. Places with
higher percentages of Medicare-eligible females had sig-
nificantly higher rates in the later period, climbing from
no difference in rates in the early period. Places with
higher percentages of African Americans had higher
rates in both periods. Places with higher percentages of
Hispanics had lower rates in the early period, but no dif-
ference in the later period. Places with higher percent-
ages of ‘all other’ populations (these are dominated by
American Indian enclaves) exhibited significantly lower
rates and these declined even more over time. Places
with a higher percentage of vulnerable eligibles had
Table 2 Estimation results, using ordinary least squares and spatial seemingly unrelated regression models
OLS Model, 2001-2005 OLS Model, 2006-2009 SSUR Model, 2001-2005 SSUR Model, 2006-2009
Coef. P > |t| Coef. P > |t| Coef. P > |t| Coef. P > |t|
Age 65-74a 0.013 0.112 -0.019 0.123 0.012 0.077 -0.016 0.144
Age 75-84a 0.059 0.000 -0.037 0.011 0.035 0.000 -0.042 0.002
Age 85 + a -0.110 0.000 -0.182 0.000 -0.077 0.000 -0.185 0.000
Femalea -0.002 0.850 0.120 0.000 -0.002 0.825 0.121 0.000
African American 0.019 0.000 0.018 0.000 0.016 0.000 0.016 0.000
Asian -0.042 0.127 0.005 0.851 -0.022 0.358 0.020 0.430
Hispanica -0.037 0.000 -0.001 0.960 -0.025 0.000 0.002 0.877
all othera -0.016 0.001 -0.023 0.000 -0.012 0.004 -0.023 0.000
Population density 0.000 0.989 0.000 0.481 0.000 0.979 0.000 0.539
Poor English -0.002 0.079 -0.004 0.028 -0.002 0.087 -0.003 0.031
Graduatea 0.087 0.000 0.035 0.000 0.065 0.000 0.023 0.000
Importance Medicarea 0.030 0.003 0.046 0.000 0.022 0.014 0.044 0.000
Average Poverty -0.032 0.000 -0.026 0.001 -0.030 0.000 -0.019 0.009
Distance endoscopy -0.026 0.000 -0.021 0.000 -0.021 0.000 -0.017 0.000
Dual/ESRD/disableda -0.024 0.000 -0.041 0.000 -0.021 0.000 -0.043 0.000
MA plan penetration -0.005 0.009 -0.004 0.182 -0.007 0.000 -0.004 0.073
Competition endoscopy 1.325 0.007 1.073 0.041 1.342 0.002 1.083 0.031
Spatial laga 0.029 0.000 0.019 0.000
Numbers highlighted in bold indicate statistically significant estimates in each model
aindicates a significant Wald test of parameter stability over time
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significantly lower rates, and this disparity increased sig-
nificantly over time.
Next we discuss market contextual factors. Places with
higher percentages of elderly with graduate or profes-
sional degrees had higher utilization rates, but this dis-
parity decreased significantly over time. Places with
higher importance of Medicare in the market exhibited
higher rates, and this disparity increased significantly over
time. Places with higher average poverty exhibited lower
rates, but this disparity did not change over time. Places
with greater distance to endoscopists exhibited lower
rates, and this remained steady over time. Places with a
more competitive endoscopy environment exhibited sig-
nificantly higher rates, and this was stable over time.
Places with higher MA plan penetration saw significantly
lower screening rates in the early period, but this disparity
became statistically weaker by the later period and the
change over time was not statistically significant.
Discussion
This study demonstrated there was an increase in endos-
copy utilization among FFS Medicare after implementa-
tion of the MMA. However, the increase was not uniform
across geography and various contextual and compos-
itional market factors predicted the observed changes in
utilization noted over time. Disparities (lower utilization
rates) for places with higher percentages of Medicare
eligible women and Hispanics decreased over time. Dis-
parities (lower utilization rates) for places with higher per-
centages of ‘other’ races or ethnicities – dominated by
American Indian enclaves - increased over time. Places
with the highest percentages of older age groups saw sig-
nificant declines over time in their screening rates, which
is appropriate as screening guidelines suggest cessation of
screening after age 75 because risks may outweigh bene-
fits. Places with higher percentages of vulnerable benefi-
ciaries exhibited lower screening rates that became even
lower over time, which suggests a widening disparity over
time for this more vulnerable group who may have greater
difficulty undergoing the procedure and/or greater risk of
complications from the procedure. Overall, the changing
composition of the Medicare eligible population helped
predict the net effects of supply and demand interaction
on area utilization rates.
The spatial lag parameter was statistically significant
and positive, suggesting that endoscopists establishing ser-
vices in one county were aware of competitors in nearby
counties. However, this effect diminished significantly over
time, reflecting the fact that utilization tended to be geo-
graphically concentrated in the early period and became
less concentrated over time as the endoscopy services dif-
fused to underserved and new market areas (Fig. 2).
Turning to contextual market factors, Managed care
spillovers were significant and negative in the early
period, but became weaker and statistically insignificant
over time. The significantly negative spillover effect in
the earlier period is consistent with findings from an
earlier paper that looked at colonoscopy and sigmoidos-
copy separately. That paper found that managed care
spillovers were significantly negative for colonoscopy,
but significantly positive for sigmoidoscopy - the older,
simpler, less risky and less costly procedure [5]. During
the early period, following expansion of Medicare coverage
for colonoscopy in 2001, the newer colonoscopy service
diffused and came to dominate FFS Medicare endoscopy
markets by 2005. The national guidelines had not yet been
established during the early period, although cost-
effectiveness evidence was mounting in favor of a com-
bined use of the two endoscopy procedures, culminating in
a complex screening protocol established as the gold
standard in 2008 [11]. Findings here suggest that the man-
aged care spillover seemed to have restraining influences
on colonoscopy utilization at first, but this gradually dimin-
ished as the procedure gained medical acceptance over the
period, and by the later period, exhibited no significant
spillover effects.
During the time of this study (2001-2009), a substantial
out-of-pocket copayment was required for endoscopic
CRC screening. With the implementation of the MMA in
2006, subsidized coverage for prescription drugs would
perhaps relax budget constraints for seniors, making such
copayments more affordable, and increase utilization
rates. Also, with drug coverage available in all MA plans,
enrollments escalated and MA plans moved into previ-
ously underserved Medicare markets (Fig. 1). With this
expansion, dissemination of best practices regarding endo-
scopic CRC screening might have spread into these newer,
less urban markets. Such dissemination could be accom-
panied by spillover effects encouraging the use of endos-
copy for CRC screening by FFS Medicare enrollees in
those markets. With both effects in play, we expected to
see an increase in utilization rates by FFS Medicare in-
sureds over time, and an increasing MA spillover onto the
FFS Medicare beneficiaries over time.
Conclusions
The data show that annual utilization rates of endoscopy
among FFS Medicare enrollees did increase over time,
and findings suggest that managed care spillover effects
did increase over time (from retraining to non-restraining).
This is great news, because as shown in Fig. 2, overall
utilization rates are low, and much improvement is needed
in many areas of the country to encourage these recom-
mended gold-standard CRC screening services. These find-
ings suggest that policies such as those enacted in the
Affordable Care Act of 2010 - which prohibited copay-
ments for CRC screening by endoscopy for enrollees in
private insurance or Medicare - are expected to result in
Mobley et al. Health Economics Review  (2017) 7:13 Page 8 of 9
higher rates of screening uptake, which would be an im-
portant topic for a future study.
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